Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
IMO pure FLUFF> they keep repeating the same news on this drug. this IMO is going below .18 soon
Great Phase3 News (see the link below) as I predicted today! Quick Double from current Bottom should be done as soon as this week!
SRRA will explode to the Dollar Land as soon as this month...
https://ih.advfn.com/stock-market/NASDAQ/sierra-oncology-SRRA/stock-news/81185051/sierra-oncology-launches-the-momentum-phase-3-clin
Three analysts give this hidden gem $3.00 target!
Huge Positive Cash Value --- $0.91 a share!
Huge Positive Book Value --- $0.79 a share!
Hyper Undervalued now!
Hyper Oversold most recently!
SRRA hit $0.285 so far! We should see $0.36 ~ $0.31 again as soon as today...
lol.yea it might quadruple when it hits .05. no way now while RS any day and dilution flying in
Again, No Any concern at all for me since SRRA is currently the Mostly Undervalued Bio-Tech hidden gem which can easily Quadtriple within a very short period based on its Huge Valuation --- both BV and CV plus Huge potential for its Phase3-FDA approval in the coming weeks/months!
Again, both Positive Huge CV ($0.91) and BV ($0.79) are higher than your target $0.70! A Four-Bagger Quick rally will drive SRRA back to $0.924 which is 32% Higher than $0.7!
Two analysts give SRRA average $3.00 target from the link below!
https://www.marketscreener.com/SIERRA-ONCOLOGY-INC-33296232/consensus/
Another Wall Street analyst gives $3.00 (which is 328.6% Higher than $0.7) target --- see the link below!
https://www.marketbeat.com/stocks/NASDAQ/SRRA/price-target/
I actually hope the price to drop more so that I could load up my boat! The Lower the price to go the more Dirt Cheap shares I'll buy!
The R/S will be a Positive (not Negative) factor since many more institution investors will be able to buy SRRA due to their strict policy!
Warning: those greedy shorters will be burned down to the ground if they Dare to short at such ridiculous low price levels! The Longs will make huge gain very soon v.s. the Shorters will be buried deeply with huge losses...
I would suggest them to cover ASAP before the Quadtriple Quick rally starts!
You seem to be bypassing my RS question ... anyone with a .70 or higher average will have no chance to recover their losses !!?!!
i disagree completely. There will be a RS announced IMO within the next 90 days, and this will be at .16 before that then crash to like .02 within 1 week after the RS announcement
Now the other two analysts give SRRA average $3.00 target from the link below!
https://www.marketscreener.com/SIERRA-ONCOLOGY-INC-33296232/consensus/
Disagreed: those greedy shorters will be burned down to the ground if they Dare to short at such ridiculous low price levels! The Longs will make huge gain very soon v.s. the Shorters will be buried deeply with huge losses...
I would suggest them to cover ASAP before the Quadtriple Quick rally starts!
it was the SAME situation with CAPS. they had tons of cash and a low SS. they went from 2.00 to .02 then RS.
You sent me a link from 2017 ?! RS is just going to be bait for more shorts to tank this again ... and anyone with an average .50 and above will be buried alive with no signs of recovery. Just like right now , I see no signs of recovery !
Zero concern for me since I own a Mostly Undervalued Bio-Tech hidden gem which can easily Quadtriple within a very short period based on its Huge Valuation --- both BV and CV plus Huge potential for its Phase3-FDA approval in the coming weeks/months!
Again, SRRA has $0.91 CV and $0.79 CV! One analyst gives $4.00 target --- see the link below!
https://www.streetinsider.com/Analyst+Comments/UPDATE%3A+Wedbush+Assumes%2C+Upgrades+Sierra+Oncology+Inc+%28SRRA%29+at+Outperform/12576449.html
I actually hope the price to drop more so that I could load up my boat!
R/S will be a Positive factor since more institutions will be able to buy SRRA due to their strict policy!
I’m concerned about the RS that they are about to beg for ... what’s your average?
You're wrong, my friend! Why "worthless"? SRRA ever did run 3.69-Bagger Quick rally from $1.11 to $4.09 recently! Based on the Same percentage of bounce it will surge to $0.8512 from $0.231. Why any worry at all?
Keep in mind: both Positive Huge CV ($0.91) and BV ($0.79) are higher than your target price --- mere $0.70!
So you’re telling me your not concerned about an RS ?
We’re screwed ... my .70 average is worthless
Wow, SRRA hit another New low $0.231 today! Why someones bought a couple of Millions shares at $0.31 ~ $0.28 the other days after cash-raising deal?
Anyway I'm happy to lower my cost base! I'll wait for huge gain very soon...
This hidden gem might bounce 4-Bagger again to hit $0.9xxx!
yep i cant agree more. This company is nothing but a share selling scam cause they always want to have the appearance of having cash while they dilute this to death to pay salaries IMO
Nothing good about this ... nick going to London paid by investors and going to present recycled PR from last year or something to lure more money into their pockets ?!
SRRA has another Good News today in the After-Hour session!
https://www.otcmarkets.com/stock/SRRA/news/story?e&id=1478986
We might see it bounce back to $0.36 again as soon as tomorrow...
With some very good news (such as Phase3-FDA milestone etc.) SRRA will explode to $0.91 (current Huge Cash Value) ~ $0.79 (current Huge Book Value) very easily!
This hidden gem is Hyper Undervalued now! Super Oversold since its most recent high $2.01!
and by stating this, it means right after they reverse split, they are going to dilute like crazy. they must be really broke and they know this drug is going to cost way more cash than they have at hand right now.
Here it is! RS COMING!...
The Series A Preferred Stock will automatically convert into shares of Common Stock upon the 5th trading date following the Company’s announcement of receiving stockholder approval for the first reverse stock split following the Offering, provided that, the Company will not effect any conversion, and the holder will not have the right to convert, subject to certain exceptions, the Series A Preferred Stock for shares of Common Stock if, as a result of such conversion, the holder, together with its affiliates and other attribution parties, would own more than 9.99% of the total number of shares of Common Stock then issued and outstanding,
yes I WAS, UNTIL THE NEWS OF ALL THAT DILUTION. UGH
Well it is what it is ... I threw more money away but I got my average down to .70 lol your opinion is a little sketch because you were pretty amped up because you talked with James and he was nice ?? lol
nope IMO. this is going to reverse by jan imo
Well I picked up more and lowered my average down to .7003 not sure if it was a good idea though lmao ???????
LOL, you will see $0.6 ~ $0.5 again before the so-called R/S since SRRA is still the Mostly Undervalued NASDQ Bio-Tech stock among nearly One Thousand NYSE/NASDQ/AMEX peers!
Super Undervalued now --- $0.91 Huge Positive Cash Value and $0.79 Huge Positive Book Value!
Hyper Oversold Within just Nine months --- from $2.01 to $0.2412!
See you’re looking at it with a .36 average ... I’m looking at this with an .88 average and by your numbers I’m still screwed . RS will demolish my .88 average and I’ll just be stuck .
you wont see .36 again IMO. you might see .33 then a big drop IMO. if not before THEN! RS coming any day IMO
As I can tell SRRA has already Bottomed out at $0.245 since the majority of weak hands were already forced out at 0.245 ~ 0.29 after over $100M Huge New cash raising deal!
We should see $0.36 ~ $0.31 again as soon as this week!
I did average down my cost base significantly since I bought my first position at 0.36.
Before any potential R/S this hidden gem will at least surge back to 0.5 ~ 0.6!
Not sure if it’s even worth it to put another 500.00 or more onto this to lower my average!? It was already rough enough to average down from 1.14 to .88 ???????
100% Misleading Info! SRRA has ZERO dilution for the common stock! They raised over $100M Huge New cash through the preferred shares and warrants which will drive this hidden gem at least Quad-triple Quick bounce to $0.98 from its current Bottom $0.245...
My concern is about the RS now ... while already sitting at -70% an RS will bury me when shorts take it back down into penny land !
look at this ridiculousness...
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
Print
Table of Contents
Filed Pursuant to Rule 424(b)(5)
Registration No. 333-225650
PROSPECTUS SUPPLEMENT
(To Prospectus dated June 21, 2018)
103,000 Shares of Series A Convertible Voting Preferred Stock
312,090,000 Series A Warrants
312,090,000 Series B Warrants
(and 727,169,700 shares of common stock underlying shares of Series A Convertible Voting Preferred Stock, Series A Warrants and Series B Warrants)
We are offering 103,000 shares of Series A convertible voting preferred stock, par value $0.001 per share, or the Series A preferred stock, Series A warrants to purchase up to an aggregate of 312,090,000 shares of common stock at an exercise price equal to $0.33, or the Series A warrants, and Series B warrants to purchase up to an aggregate of 102,989,700 shares of common stock at an exercise price equal to $0.33, or the Series B warrants, and together with the Series A warrants, the warrants. Each share of Series A preferred stock we sell in this offering will be accompanied by (i) 3,030 Series A warrants to purchase 3,030 shares of common stock (which equates to 100% warrant coverage), and (ii) 3,030 Series B warrant to purchase 1,000 shares of common stock (which equates to 33% warrant coverage). Each share of Series A preferred stock and the accompanying warrants will be sold at a combined purchase price of $1,000.
The shares of Series A preferred stock and the accompanying warrants will be issued separately, but can only be purchased together in this offering.
No public market currently exists for the securities we are offering, and we do not intend to apply to list the Series A preferred stock or the warrants on The Nasdaq Global Market, any other national securities exchange or any other nationally recognized trading system.
Pretty much this means nothing for someone with an .88 average right ?! With an RS my .88 will not even be able to break even at all because it will tank immediately ???????
its TOXIC dilution. youre inaccurate. and there will be MILLIONS to sell and as i posted before. they are looking to do a RS
Another Gap-Up day today --- $0.2784 so far and $0.28 last evening! Yesterday Pre-market's high was $0.31!
SRRA will have near $200M Huge Cash on hand after this Non-dilutive public offerings!
theres absolutely NO hope of nasdaq compliance now with those officers selling ALL those preferred shares and warrants. omg.
they will DEFINITELY RS the stock as they hint to in this recent filing. I smell a lawsuit maybe?
But but but James was so nice to you on the phone ???????
We intend to use the net proceeds from this offering to fund MOMENTUM, our planned Phase 3 clinical trial of momelotinib, as well as for general corporate purposes.
and they will be doing this until the stock is at .02. for GENERAL PURPOSES means PAYING salaries duh
Huge news today! $0.31 so far! SRRA might bounce back to $0.36 again as soon as today...
Last evening's Very Stupid $0.245 ~ $0.2999 Emotional sellers must kick themselves now!
Warning everyone?!? Lmao you were just amped up about taking to IR James and telling everyone to call him ...
here it is! RS. I WARNED EVERYONE HERE...
The Series A preferred stock will automatically convert into shares of our common stock upon the 5th trading date following the announcement of us receiving stockholder approval for the first reverse stock split following this offering, provided that, we will not effect any conversion, and the holder will not have the right to convert,
this stock will be .05 soon cause of this RS
Well that’s horrible ... I’m about to get buried -100% here I come !
How do Baker Bros and Perceptive Advisors get sucked into something like this? They are pros and they are getting hosed too.
i will NEVER let these crooks have my hardearned money again! they will certainly be delisted soon
Interesting quote from today's pr update:
"Chronic, progressive anemia is a key hallmark feature of myelofibrosis and the most important negative prognostic indicator of reduced survival in this disease. Approximately 60% of patients are anemic and 45% are transfusion dependent within one year of diagnosis, with most patients ultimately progressing to transfusion dependency. Unfortunately, currently approved JAK inhibitor therapies induce or worsen anemia, exacerbating this significant unmet medical need in anemic myelofibrosis patients," said Dr. Barbara Klencke, Chief Development Officer of Sierra Oncology. "The marked systemic inflammation seen in myelofibrosis leads to increased ACVR1 activity which in turn increases secretion of hepcidin, resulting in perturbed iron homeostasis and an iron-restricted anemia. Momelotinib's inhibition of ACVR1 in addition to JAK1 and JAK2, unique amongst the JAK inhibitor class, results in notable reductions of both hepcidin and inflammation, restoring iron homeostasis and RBC production, thereby alleviating anemia and transfusion dependency."
RNsidersbuying?
https://old.nasdaq.com/quotes/insiders/klencke-barbara-970670
I AM glad that they beat EPS est. by .04. At least THATS good! SRRA
AGAIN i ask. where is the news for the analyst upgrade? i cant find it. and can you put it up as a stickie?
can you give us link for analyst upgrade? i dont see that!
Followers
|
29
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
777
|
Created
|
11/30/15
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |